Sandbox:Preeti: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 109: | Line 109: | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | + | | align="center" style="background:#F5F5F5;" + | + | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |± | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |Nl | ||
| align="left" style="background:#F5F5F5;" + | | | align="left" style="background:#F5F5F5;" + | | ||
* Painless peripheral adenopathy in the cervical, axillary, inguinal, and/or femoral regions | * Painless peripheral adenopathy in the cervical, axillary, inguinal, and/or femoral regions | ||
Line 126: | Line 126: | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* Cytopenia | * Cytopenia | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + |NA | ||
| align="center" style="background:#F5F5F5;" + | | | align="center" style="background:#F5F5F5;" + | | ||
* CD21 | * CD21 |
Revision as of 19:29, 7 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Preeti Singh, M.B.B.S.[2]
Category | Disease | Etiology | Clinical manifestations | Paraclinical findings | Gold standard | Associated findings | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Lab findings | |||||||||||||||||||||||
Demography | History | Symptoms | Signs | CBC | PBS | PT/PTT | Immunochemistry | Histopathology | Other | ||||||||||||||
Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | Hepatosplenomegaly | Other | WBC | Hb | Plt | |||||||||||||
HL | |||||||||||||||||||||||
Hodgkin's Lymphoma | |||||||||||||||||||||||
NHL | |||||||||||||||||||||||
B Cell Lymphoma | Precursor B-cell lymphoblastic leukemia/lymphoma |
|
|||||||||||||||||||||
Follicular lymphoma |
|
|
|
Only in 20% of patients: | + | + | ± | Nl |
|
+ | ↓ | ↓ | Nl to ↓ |
|
NA |
|
|
|
Lymph node biopsy |
| |||
Mantle cell lymphoma |
|
|
Abdominal distention |
|
+ |
|
|
↓ | Nl to ↓ |
|
|
|
|||||||||||
Diffuse large B cell lymphoma |
|
|
|
↓ | ↓ | Nl to ↓ |
|
Centroblastic
Immunoblastic
Anaplastic
|
|
||||||||||||||
Category | Disease | Etiology | Demography | History | Constitutional symptoms | Rash | Abdominal pain | Diarrhea | V/S | Mass | Hepatosplenomegaly | Other | WBC | Hb | Plt | PBS | PT/PTT | Immunochemistry | Histopathology | Other lab findings | Gold standard | Associated findings | |
Burkitt lymphoma |
|
|
|
|
|||||||||||||||||||
B cell chronic lymphocytic leukemia/small lymphocytic lymphoma |
|
||||||||||||||||||||||
Marginal zone lymphoma | Extranodal marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue (MALT) type |
|
|||||||||||||||||||||
Splenic marginal zone lymphoma |
|
|
|||||||||||||||||||||
Nodal marginal zone B-cell lymphoma |
|
+ |
|
|
|
| |||||||||||||||||
Lymphoplasmacytic lymphoma (Waldenstrom’s macroglobulinemia) |
|
||||||||||||||||||||||
Hairy cell leukemia |
|
|
|
||||||||||||||||||||
Precursor T-cell lymphoblastic leukemia/lymphoma |
|
||||||||||||||||||||||
Adult T cell leukemia/lymphoma | |||||||||||||||||||||||
T cell lymphoma | Anaplastic large cell lymphoma | ||||||||||||||||||||||
Cutaneous T-cell lymphoma | Mycosis fungoides / Sézary syndrome |
|
|
|
|||||||||||||||||||
Peripheral T-cell lymphoma | Subcutaneous panniculitis-like T-cell lymphoma | ||||||||||||||||||||||
Hepatosplenic gamma-delta T-cell lymphoma | |||||||||||||||||||||||
Enteropathy-type intestinal T-cell lymphoma | |||||||||||||||||||||||
Extranodal T-cell lymphoma, nasal type | |||||||||||||||||||||||
Angioimmunoblastic T-cell lymphoma | |||||||||||||||||||||||
Peripheral T-cell lymphoma, unspecified |